Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

JAMA Oncology

Volumn 3, Issue 5, 2017, Pages 636-651

  Haycock, Philip C ^a   Burgess, Stephen ^b   Nounu, Aayah ^a   Zheng, Jie ^a   Okoli, George N ^a   Bowden, Jack ^a   Wade, Kaitlin Hazel ^a   Timpson, Nicholas J ^a   Evans, David M ^a,c   Willeit, Peter ^d   Aviv, Abraham ^e   Gaunt, Tom R ^a   Hemani, Gibran ^a   Mangino, Massimo ^f,g   Ellis, Hayley Patricia ^a   Kurian, Kathreena M ^a   Pooley, Karen A ^b   Eeles, Rosalind A ^h   Lee, Jeffrey E ⁱ   Fang, Shenying ⁱ   Chen, Wei V ⁱ   Law, Matthew H ^j   Bowdler, Lisa M ^j   Iles, Mark M ^k   Yang, Qiong ^l   Worrall, Bradford B ^m   Markus, Hugh Stephen ^b   Hung, Rayjean J ^n,o   Amos, Chris I ^p   Spurdle, Amanda B ^j   Thompson, Deborah J ^b   O'Mara, Tracy A ^j   Wolpin, Brian ^q   Amundadottir, Laufey ^r   Stolzenberg Solomon, Rachael ^r   Trichopoulou, Antonia ^s,t   Onland Moret, N Charlotte ^u   Lund, Eiliv ^v   Duell, Eric J ^w   Canzian, Federico ^x   Severi, Gianluca ^y,z,aa,ab   Overvad, Kim ^ac   Gunter, Marc J ^ad   Tumino, Rosario ^ae   Svenson, Ulrika ^af   Van Rij, Andre ^ag   Baas, Annette F ^u   Bown, Matthew J ^ah   Samani, Nilesh J ^ah   Van t'Hof, Femke N G ^u   Tromp, Gerard ^ai,aj   Jones, Gregory T ^ag   Kuivaniemi, Helena ^ai,aj   Elmore, James R ^ak   Johansson, Mattias ^al   Mckay, James ^al   Scelo, Ghislaine ^al   Carreras Torres, Robert ^al   Gaborieau, Valerie ^al   Brennan, Paul ^al   Bracci, Paige M ^am   Neale, Rachel E ^j   Olson, Sara H ^an   Gallinger, Steven ⁿ   Li, Donghui ⁱ   Petersen, Gloria M ^ao   Risch, Harvey A ^ap   Klein, Alison P ^aq   Han, Jiali ^ar,as   Abnet, Christian C ^r   Freedman, Neal D ^r   Taylor, Philip R ^r   Maris, John M ^at   Aben, Katja K ^au,av   Kiemeney, Lambertus A ^au   Vermeulen, Sita H ^au   Wiencke, John K ^am,aw   Walsh, Kyle M ^am,aw   Wrensch, Margaret ^am,aw   Rice, Terri ^aw   Turnbull, Clare ^h,ax   Litchfield, Kevin ^ay   Paternoster, Lavinia ^a   Standl, Marie ^az   Abecasis, Gonçalo R ^ba   SanGiovanni, John Paul ^bb,bc   Li, Yong ^bd   Mijatovic, Vladan ^be   Sapkota, Yadav ^j   Low, Siew Kee ^bf   Zondervan, Krina T ^bg,bh   Montgomery, Grant W ^j   Nyholt, Dale R ^j,bi   Van Heel, David A ^ax   Hunt, Karen ^ax   Arking, Dan E ^aq   Ashar, Foram N ^aq   Sotoodehnia, Nona ^bj   Woo, Daniel ^bk   Rosand, Jonathan ^bl   Comeau, Mary E ^bm   Brown, W Mark ^bm   Silverman, Edwin K ^bn   Hokanson, John E ^bo   Cho, Michael H ^bn   Hui, Jennie ^bp,bq,br   Ferreira, Manuel A ^j   Thompson, Philip J ^br   Morrison, Alanna C ^bs   Felix, Janine F ^bt   Smith, Nicholas L ^bu   Christiano, Angela M ^bv   Petukhova, Lynn ^bv   Betz, Regina C ^bw   Fan, Xing ^bx   Zhang, Xuejun ^bx   Zhu, Caihong ^bx   Langefeld, Carl D ^bm   Thompson, Susan D ^bk   Wang, Feijie ^by   Lin, Xu ^by   Schwartz, David A ^bz   Fingerlin, Tasha ^ca   Rotter, Jerome I ^cb   Cotch, Mary Frances ^cc   Jensen, Richard A ^bj,bu   Munz, Matthias ^cd,ce   Dommisch, Henrik ^cd   Schaefer, Arne S ^cd   Han, Fang ^cf   Ollila, Hanna M ^cg   Hillary, Ryan P ^cg   Albagha, Omar ^ch,ci   Ralston, Stuart H ^ci   Zeng, Chenjie ^cj   Zheng, Wei ^cj   Shu, Xiao Ou ^cj   Reis, Andre ^ck   Uebe, Steffen ^ck   Hüffmeier, Ulrike ^ck   Kawamura, Yoshiya ^cl   Otowa, Takeshi ^cm,cn   Sasaki, Tsukasa ^co   Hibberd, Martin Lloyd ^cp   Davila, Sonia ^cp   Xie, Gang ^n,o   Siminovitch, Katherine ^n,o   Bei, Jin Xin ^cq   Zeng, Yi Xin ^cq,cr   Försti, Asta ^x,cs   Chen, Bowang ^x   Landi, Stefano ^ct   Franke, Andre ^cu   Fischer, Annegret ^cu,cv   Ellinghaus, David ^cv   Flores, Carlos ^cw,cx   Noth, Imre ^cy   Ma, Shwu Fan ^cy   Foo, Jia Nee ^cp   Liu, Jianjun ^cp   Kim, Jong Won ^cz   Cox, David G ^da   Delattre, Olivier ^db   Mirabeau, Olivier ^db   Skibola, Christine F ^dc   Tang, Clara S ^dd   Garcia Barcelo, Merce ^dd   Chang, Kai Ping ^de   Su, Wen Hui ^de,df   Chang, Yu Sun ^df   Martin, Nicholas G ^j   Gordon, Scott ^j   Wade, Tracey D ^dg   Lee, Chaeyoung ^dh   Kubo, Michiaki ^di   Cha, Pei Chieng ^dj   Nakamura, Yusuke ^dk   Levy, Daniel ^dl,dm   Kimura, Masayuki ^e   Hwang, Shih Jen ^dl,dm   Hunt, Steven ^dn   Spector, Tim ^f   Soranzo, Nicole ^do   Manichaikul, Ani W ^dp   Barr, R Graham ^dq   Kahali, Bratati ^dr   Speliotes, Elizabeth ^dr   Yerges Armstrong, Laura M ^ds   Cheng, Ching Yu ^dt,du,dv   Jonas, Jost B ^dw,dx   Wong, Tien Yin ^dt,du,dv   Fogh, Isabella ^f   Lin, Kuang ^f   Powell, John F ^f   Rice, Kenneth ^bu   Relton, Caroline L ^a   Martin, Richard M ^a   Davey Smith, George ^a   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^k UNIVERSITY OF LEEDS   (United Kingdom)

^l BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ MOUNT SINAI HOSPITAL   (Canada)

^o UNIVERSITY OF TORONTO   (Canada)

^p DARTMOUTH MEDICAL SCHOOL   (United States)

^q DANA FARBER CANCER INSTITUTE   (United States)

^r NATIONAL CANCER INSTITUTE   (United States)

^s HELLENIC HEALTH FOUNDATION   (Greece)

^t UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^u UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^v UNIVERSITY OF TROMSØ   (Norway)

^w CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^x GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^y UNIVERSITÉ PARIS SACLAY   (France)

^z INSTITUT GUSTAVE ROUSSY   (France)

^aa Human Genetics Foundation (HuGeF)   (Italy)

^ab UNIVERSITY OF MELBOURNE   (Australia)

^ac AARHUS UNIVERSITY   (Denmark)

^ad IMPERIAL COLLEGE LONDON   (United Kingdom)

^ae CIVILE M P AREZZO HOSPITAL   (Italy)

^af UMEÅ UNIVERSITY   (Sweden)

^ag UNIVERSITY OF OTAGO   (New Zealand)

^ah UNIVERSITY OF LEICESTER   (United Kingdom)

^ai UNIVERSITY OF STELLENBOSCH   (South Africa)

^aj WEIS CENTER FOR RESEARCH   (United States)

^ak GEISINGER HEALTH SYSTEM   (United States)

^al INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^am UNIVERSITY OF CALIFORNIA   (United States)

^an MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ao Mayo Clinic   (United States)

^ap YALE CANCER CENTER   (United States)

^aq JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ar INDIANA UNIVERSITY   (United States)

^as INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^at UNIVERSITY OF PENNSYLVANIA   (United States)

^au RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^av Netherlands Comprehensive Cancer Organization   (Netherlands)

^aw UNIVERSITY OF CALIFORNIA   (United States)

^ax QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^ay INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^az INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ba UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^bb NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^bc GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bd UNIVERSITY OF FREIBURG   (Germany)

^be UNIVERSITY OF VERONA   (Italy)

^bf RIKEN Center for Integrative Medical Sciences   (Japan)

^bg UNIVERSITY OF OXFORD   (United Kingdom)

^bh UNIVERSITY OF OXFORD   (United Kingdom)

^bi QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^bj UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^bk UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^bl MASSACHUSETTS GENERAL HOSPITAL   (United States)

^bm WAKE FOREST SCHOOL OF MEDICINE   (United States)

^bn BRIGHAM AND WOMEN S HOSPITAL   (United States)

^bo UNIVERSITY OF COLORADO   (United States)

^bp SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^bq PATHWEST LABORATORY MEDICINE   (Australia)

^br UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^bs UNIVERSITY OF TEXAS   (United States)

^bt ERASMUS MEDICAL CENTER   (Netherlands)

^bu UNIVERSITY OF WASHINGTON   (United States)

^bv Och Spine at New York Presbyterian Hospitals   (United States)

^bw UNIVERSITY OF BONN   (Germany)

^bx ANHUI MEDICAL UNIVERSITY   (China)

^by UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^bz UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ca DEPARTMENT OF MEDICINE   (United States)

^cb HARBOR UCLA MEDICAL CENTER   (United States)

^cc NATIONAL EYE INSTITUTE   (United States)

^cd CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ce UNIVERSITY OF LÜBECK   (Germany)

^cf PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^cg STANFORD UNIVERSITY   (United States)

^ch HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

^ci UNIVERSITY OF EDINBURGH   (United Kingdom)

^cj VANDERBILT INGRAM CANCER CENTER   (United States)

^ck UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^cl SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^cm UNIVERSITY OF TOKYO   (Japan)

^cn TEIKYO HEISEI UNIVERSITY   (Japan)

^co UNIVERSITY OF TOKYO   (Japan)

^cp GENOME INSTITUTE OF SINGAPORE   (Singapore)

^cq SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^cr PEKING UNION MEDICAL COLLEGE   (China)

^cs LUND UNIVERSITY   (Sweden)

^ct UNIVERSITY OF PISA   (Italy)

^cu UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^cv UNIVERSITY OF KIEL   (Germany)

^cw HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^cx INSTITUTO DE SALUD CARLOS III   (Spain)

^cy UNIVERSITY OF CHICAGO   (United States)

^cz Sungkyunkwan University School of Medicine   (South Korea)

^da CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^db INSTITUT CURIE   (France)

^dc UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^dd UNIVERSITY OF HONG KONG   (Hong Kong)

^de CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^df CHANG GUNG UNIVERSITY   (Taiwan)

^dg FLINDERS UNIVERSITY   (Australia)

^dh Soongsil University   (South Korea)

^di UNIVERSITY OF HEIDELBERG   (Germany)

^dj KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^dk University of Chicago   (United States)

^dl FRAMINGHAM HEART STUDY   (United States)

^dm NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^dn WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^do WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^dp UNIVERSITY OF VIRGINIA   (United States)

^dq NewYork Presbyterian Hospital   (United States)

^dr UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^ds UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^dt SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^du NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^dv DUKE NUS MEDICAL SCHOOL   (Singapore)

^dw CAPITAL MEDICAL UNIVERSITY   (China)

^dx MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVASCULAR DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GERMLINE MUTATION; HUMAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NEOPLASM; PROCEDURES; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; TELOMERE HOMEOSTASIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 85019502119     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.5945     Document Type: Article

References (132)

1. Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153 (6):1194-1217.
3. Samani NJ, van der Harst P. Biological ageing and cardiovascular disease. Heart. 2008;94(5):537-539.
4. Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014;10(3):e1004191.
5. Houben JMJ, Moonen HJJ, van Schooten FJ, Hageman GJ. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med. 2008;44(3):235-246.
6. Marchesi V. Risk factors: short telomeres: association with cancer survival and risk. Nat Rev Clin Oncol. 2013;10(5):247.
7. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014;349(6):g4227.
8. Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population. J Natl Cancer Inst. 2015;107(6):djv074.
9. Zhao J, Miao K, Wang H, Ding H, Wang DW. Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS One. 2013;8(11):e79993.
10. Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ, Tybjærg-Hansen A, Bojesen SE. Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 2013;105(7):459-468.
11. Ma H, Zhou Z, Wei S, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 2011;6(6):e20466.
12. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1238-1250.
13. Pooley KA, Sandhu MS, Tyrer J, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010;70(8):3170-3176.
14. Hou L, Joyce BT, Gao T, et al. Blood telomere length attrition and cancer development in the Normative Aging Study cohort. EBioMedicine. 2015;2(6):591-596.
15. Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42(Database issue):D1001-D1006.
16. Burdett T, Hall P, Hastings E, et al. The NHGRI-EBI Catalog of published genome-wide association studies. http://www.ebi.ac.uk/gwas. Accessed January 15, 2015.
17. Pooley KA, Bojesen SE, Weischer M, et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet. 2013;22(24):5056-5064.
18. Mangino M, Hwang S-J, Spector TD, et al. Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet. 2012;21(24):5385-5394.
19. Prescott J, Kraft P, Chasman DI, et al. Genome-wide association study of relative telomere length. PLoS One. 2011;6(5):e19635.
20. Gu J, Chen M, Shete S, et al. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila). 2011;4(4):514-521.
21. Codd V, Nelson CP, Albrecht E, et al; CARDIoGRAM consortium. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422-427, e1-e2.
22. Codd V, Mangino M, van der Harst P, et al; Wellcome Trust Case Control Consortium. Common variants near TERC are associated with mean telomere length. Nat Genet. 2010;42(3):197-199.
23. Liu Y, Cao L, Li Z, et al. A genome-wide association study identifies a locus on TERT for mean telomere length in Han Chinese. PLoS One. 2014;9(1):e85043.
24. Saxena R, Bjonnes A, Prescott J, et al. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort. Circ Cardiovasc Genet. 2014;7(3):287-295.
25. Levy D, Neuhausen SL, Hunt SC, et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA. 2010;107(20):9293-9298.
26. Hindorff LALA, MacArthur J, Morales J, et al. A catalog of published genome-wide association studies. https://www.genome.gov/gwastudies. Accessed January 15, 2015.
27. Chêne G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol. 1996;144(6):610-621.
28. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG; EPIC- InterAct Consortium. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543-552.
29. Thomas DC, Lawlor DA, Thompson JR. Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol. 2007;17(7):511-513.
30. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525.
31. VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M, Kraft P. Methodological challenges in mendelian randomization. Epidemiology. 2014;25(3):427-435.
32. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304-314.
33. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. https://www.seer.cancer.gov/. Accessed August 1, 2015.
34. Tomasetti C, Vogelstein B. Cancer etiology: variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347(6217):78-81.
35. US Census Bureau. Welcome to QuickFacts: United States. https://www.census.gov/quickfacts/table/PST045216/00. Accessed July 11, 2016.
36. R Core Team. A language and environment for statistical computing, 2013. https://cran.r-project.org/bin/windows/base/old/3.1.2/. Accessed 2015.
37. Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med. 2011;30(11):1312-1323.
38. Rafnar T, Sulem P, Thorleifsson G, et al. Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum Mol Genet. 2014;23(20):5545-5557.
39. Michailidou K, Hall P, Gonzalez-Neira A, et al; Breast and Ovarian Cancer Susceptibility Collaboration; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); kConFab Investigators; Australian Ovarian Cancer Study Group; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353-361, e1-e2.
40. Zhang C, Doherty JA, Burgess S, et al; GECCO and GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015;24(18):5356-5366.
41. Schumacher FR, Schmit SL, Jiao S, et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun. 2015;6:7138.
42. Spurdle AB, Thompson DJ, Ahmed S, et al; Australian National Endometrial Cancer Study Group; National Study of Endometrial Cancer Genetics Group. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet. 2011;43(5):451-454.
43. Painter JN, O'Mara TA, Batra J, et al; National Study of Endometrial Cancer Genetics Group (NSECG); CHIBCHA Consortium; Australian National Endometrial Cancer Study Group (ANECS); RENDOCAS; Australian Ovarian Cancer Study (AOCS); GENICA Network. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum Mol Genet. 2015;24(5):1478-1492.
44. Abnet CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42(9):764-767.
45. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905-908.
46. Walsh KM, Codd V, Rice T, et al; ENGAGE Consortium Telomere Group. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015;6(40):42468-42477.
47. McKay JD, Truong T, Gaborieau V, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet. 2011;7(3):e1001333.
48. Purdue MP, Johansson M, Zelenika D, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2011;43(1):60-65.
49. Wang Y, McKay JD, Rafnar T, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014;46(7):736-741.
50. Law MH, Bishop DT, Lee JE, et al; GenoMEL Consortium; Essen-Heidelberg Investigators; SDH Study Group; Q-MEGA and QTWIN Investigators; AMFS Investigators; ATHENS Melanoma Study Group. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet. 2015;47(9):987-995.
51. Zhang M, Song F, Liang L, et al. Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet. 2013;22(14):2948-2959.
52. Diskin SJ, Capasso M, Schnepp RW, et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet. 2012;44(10):1126-1130.
53. Pharoah PDP, Tsai Y-Y, Ramus SJ, et al; Australian Cancer Study; Australian Ovarian Cancer Study Group. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013;45(4):362-370, e1-e2.
54. Wolpin BM, Rizzato C, Kraft P, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014;46(9):994-1000.
55. Eeles RA, Olama AA, Benlloch S, et al; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet. 2013;45(4):385-391, e1-e2.
56. Al Olama AA, Kote-Jarai Z, Berndt SI, et al; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; COGS (Collaborative Oncological Gene-environment Study) Consortium; GAME-ON/ELLIPSE Consortium. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014;46(10):1103-1109.
57. Turnbull C, Rapley EA, Seal S, et al; UK Testicular Cancer Collaboration. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010;42(7):604-607.
58. Rapley EA, Turnbull C, Al Olama AA, et al; UK Testicular Cancer Collaboration. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41(7):807-810.
59. Betz RC, Petukhova L, Ripke S, et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966.
60. Paternoster L, Standl M, Waage J, et al; Australian Asthma Genetics Consortium (AAGC); EArly Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet. 2015;47(12):1449-1456.
61. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42(4):295-302.
62. Liu JZ, van Sommeren S, Huang H, et al; International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979-986.
63. Thompson SD, Marion MC, Sudman M, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum. 2012;64(8):2781-2791.
64. Beecham AH, Patsopoulos NA, Xifara DK, et al; International Multiple Sclerosis Genetics Consortium (IMSGC); Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353-1360.
65. Schaefer AS, Richter GM, Nothnagel M, et al. A genome-wide association study identifies GLT6D1 as a susceptibility locus for periodontitis. Hum Mol Genet. 2010;19(3):553-562.
66. Stahl EA, Raychaudhuri S, Remmers EF, et al; BIRAC Consortium; YEAR Consortium. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42(6):508-514.
67. Bown MJ, Jones GT, Harrison SC, et al; CARDIoGRAM Consortium; Global BPgen Consortium; DIAGRAM Consortium; VRCNZ Consortium. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet. 2011;89(5):619-627.
68. Gretarsdottir S, Baas AF, Thorleifsson G, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet. 2010;42(8):692-697.
69. Jones GT, Bown MJ, Gretarsdottir S, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet. 2013;22(14):2941-2947.
70. Harrison SC, Smith AJP, Jones GT, et al; Aneurysm Consortium. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2013;34(48):3707-3716.
71. Elmore JR, Obmann MA, Kuivaniemi H, et al. Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association. J Vasc Surg. 2009;49(6):1525-1531.
72. Borthwick KM, Smelser DT, Bock JA, et al. ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: algorithm development and Konstanz information miner workflow. Int J Biomed Data Min. 2015;4(1):256-263.
73. Schunkert H, König IR, Kathiresan S, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333-338.
74. Smith NL, Felix JF, Morrison AC, et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. 2010;3(3):256-266.
75. Woo D, Falcone GJ, Devan WJ, et al; International Stroke Genetics Consortium. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet. 2014;94(4):511-521.
76. Malik R, Freilinger T, Winsvold BS, et al; International Headache Genetics Consortium; METASTROKE Collaboration of the International Stroke Genetics Consortium. Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology. 2015;84(21):2132-2145.
77. Traylor M, Farrall M, Holliday EG, et al; Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2); International Stroke Genetics Consortium. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951-962.
78. Barrett JC, Clayton DG, Concannon P, et al; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703-707.
79. Burren OS, Adlem EC, Achuthan P, Christensen M, Coulson RMR, Todd JA. T1DBase: update 2011, organization and presentation of large-scale data sets for type 1 diabetes research. Nucleic Acids Res. 2011;39(Database issue):D997-D1001.
80. Morris AP, Voight BFB, Teslovich TMT, et al; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-990.
81. Fritsche LG, Chen W, Schu M, et al; AMD Gene Consortium. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45(4):433-439, e1-e2.
82. Jensen RA, Sim X, Li X, et al; Blue Mountains Eye Study GWAS Team; CKDGen Consortium. Genome-wide association study of retinopathy in individuals without diabetes. PLoS One. 2013;8(2):e54232.
83. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448(7152):470-473.
84. Ferreira MAR, Matheson MC, Duffy DL, et al; Australian Asthma Genetics Consortium. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011;378(9795):1006-1014.
85. Cho MH, McDonald M-LN, Zhou X, et al; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med. 2014;2(3):214-225.
86. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45(6):613-620.
87. Fogh I, Ratti A, Gellera C, et al; SLAGEN Consortium and Collaborators. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23(8):2220-2231.
88. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al; European Alzheimer's Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer's Disease; Alzheimer's Disease Genetic Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
89. Boraska V, Franklin CS, Floyd JAB, et al; Wellcome Trust Case Control Consortium 3. A genome-wide association study of anorexia nervosa. Mol Psychiatry. 2014;19(10):1085-1094.
90. Smoller JW, Hospital MG; Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371-1379.
91. Sklar P, Ripke S, Scott LJ, et al; Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43(10):977-983.
92. Ripke S, Wray NR, Lewis CM, et al; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18(4):497-511.
93. Ripke S, Neale BM, Corvin A, et al; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-427.
94. Scharf JM, Yu D, Mathews CA, et al; North American Brain Expression Consortium; UK Human Brain Expression Database. Genome-wide association study of Tourette's syndrome. Mol Psychiatry. 2013;18(6):721-728.
95. Köttgen A, Pattaro C, Böger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5):376-384.
96. Nyholt DR, Low S-K, Anderson CA, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012;44(12):1355-1359.
97. Seow WJ, Cawthon RM, Purdue MP, et al. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res. 2014;74(15):4090-4098.
98. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ. 2005;330(7499):1076-1079.
99. Anic GM, Sondak VK, Messina JL, et al. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 2013;37(4):434-439.
100. Pellatt AJ, Wolff RK, Torres-Mejia G, et al. Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Genes Chromosomes Cancer. 2013;52(7):595-609.
101. Caini S, Raimondi S, Johansson H, et al. Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis. J Dermatol Sci. 2015;80(3):168-174.
102. Sanchez-Espiridion B, Chen M, Chang JY, et al. Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res. 2014;74(9):2476-2486.
103. Campa D, Mergarten B, De Vivo I, et al. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2447-2454.
104. Cui Y, Cai Q, Qu S, et al. Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1807-1813.
105. De Vivo I, Prescott J, Wong JYY, Kraft P, Hankinson SE, Hunter DJ. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1152-1156.
106. Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129(2):415-421.
107. Hofmann JN, Lan Q, Cawthon R, et al. A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22(5):997-1000.
108. Julin B, Shui I, Heaphy CM, et al. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer. Br J Cancer. 2015;112(4):769-776.
109. Kim S, Sandler DP, Carswell G, et al. Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study. Cancer Causes Control. 2011;22(7):1061-1066.
110. Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009;15(23):7429-7433.
111. Lee I-M, Lin J, Castonguay AJ, Barton NS, Buring JE, Zee RYL. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study. Clin Chem Lab Med. 2010;48(2):259-262.
112. Liang G, Qureshi AA, Guo Q, De Vivo I, Han J. No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(5):1043-1045.
113. Lynch SM, Major JM, Cawthon R, et al. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer. 2013;133(11):2672-2680.
114. McGrath M, Wong JYY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16(4):815-819.
115. Nan H, Du M, De Vivo I, et al. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 2011;71(21):6758-6763.
116. Prescott J, McGrath M, Lee I-M, Buring JE, De Vivo I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer. 2010;116(18):4275-4282.
117. Qu S, Wen W, Shu X-O, et al. Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am J Epidemiol. 2013;177(7):617-624.
118. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2649-2655.
119. Shen M, Cawthon R, Rothman N, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer. 2011;73(2):133-137.
120. Walcott F, Rajaraman P, Gadalla SM, et al. Telomere length and risk of glioma. Cancer Epidemiol. 2013;37(6):935-938.
121. Zee RYL, Castonguay AJ, Barton NS, Buring JE. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2280-2282.
122. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304(1):69-75.
123. Iles MM, Bishop DT, Taylor JC, et al; AMFS Investigators; IBD investigators; QMEGA and QTWIN Investigators; SDH Study Group; GenoMEL Consortium. The effect on melanoma risk of genes previously associated with telomere length. J Natl Cancer Inst. 2014;106(10):dju267.
124. Ojha J, Codd V, Nelson CP, et al; ENGAGE Consortium Telomere Group. Genetic variation associated with longer telomere length increases risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1043-1049.
125. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012;13(10):693-704.
126. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet. 2009;10(46):45-61.
127. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
128. Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol. 2007;3(10):640-649.
129. Stone RC, Horvath K, Kark JD, Susser E, Tishkoff SA, Aviv A. Telomere length and the cancer-atherosclerosis trade-off. PLoS Genet. 2016;12(7):e1006144.
130. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177-1184.
131. Burgess S, Butterworth AS, Thompson JR. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors. J Clin Epidemiol. 2016;69:208-216.
132. Centers for Disease Control and Prevention. Deaths and mortality. https://www.cdc.gov/nchs/fastats/deaths.htm. Accessed July 14, 2016.